November 30, 2021
Japan’s health ministry plans to set up a new rule for potentially big-selling drugs with revenue exceeding a certain threshold, it was learned on November 29. To cope with the likes of Biogen’s Alzheimer’s treatment aducanumab, the rule calls for...read more